Home › Funds › Capital Group › Tax-Exempt Fund of California
Fund family: Capital Group · Filed by AMERICAN FUNDS TAX EXEMPT SERIES II / CA (CIK 794389) · SEC series S000009239
Share classes and tickers: EXCAX (C000180000), TAFTX (C000025170), TECCX (C000025172), TECFX (C000025173), TEFEX (C000068592), TTCAX (C000189456)
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 2,442 with, 181 against, 0 abstentions (not counted as with management); 5 items carried no recommendation; 3 split votes are in neither count. Shareholder proposals: 43 FOR, 139 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Capital Group’s manager page (120,065 ballot items across 80 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Capital Group | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 98.9% | 2,329 | 96.6% | 98,284 |
| Backed environmental and social shareholder proposals at US companies | 1.1% | 94 | 1.3% | 2,130 |
Each ballot item this fund voted is set against the votes of the other Capital Group funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Capital Group funds on 4 items (0.2% of the 2,336 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Capital Group funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| Oracle Corporation | 2025-11-18 | Advisory Vote to Approve the Compensation of our Named Executive Officers | Against | FOR — 15 of 23 Capital Group funds | Against | Passed (calculated), 81.9% support |
| AstraZeneca PLC | 2026-04-09 | Authorise Issue of Equity without Pre-emptive Rights | For | AGAINST — 10 of 16 Capital Group funds | For | — |
| AstraZeneca PLC | 2026-04-09 | Authorise Issue of Equity without Pre-emptive Rights in Connection with an Acquisition or Other Capital Investment | For | AGAINST — 10 of 16 Capital Group funds | For | — |
| Berkshire Hathaway Inc. | 2026-05-02 | Shareholder Shareholder proposal requesting that the Company issue a report disclosing the Board's oversight framework for workforce and human-capital management across its operating subsidiaries. | Against | FOR — 4 of 5 Capital Group funds | For | — |
Download all 4 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 90.4% of this fund’s 2,623 such votes could be given a sector; the other 252 (9.6%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 486 | 26 | 5.3% |
| Consumer Discretionary | 437 | 43 | 9.8% |
| Technology | 343 | 48 | 14.0% |
| Industrials | 300 | 17 | 5.7% |
| Health Care | 221 | 16 | 7.2% |
| Utilities | 173 | 6 | 3.5% |
| Consumer Staples | 132 | 8 | 6.1% |
| Real Estate | 117 | 0 | 0.0% |
| Energy | 91 | 5 | 5.5% |
| Basic Materials | 40 | 1 | 2.5% |
| Telecommunications | 31 | 3 | 9.7% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 1,828 | 0 |
| Audit-related | 188 | 0 |
| Corporate Governance | 184 | 71 |
| Say-on-Pay | 168 | 0 |
| Compensation | 93 | 6 |
| Capital Structure | 60 | 0 |
| Other Social Issues | 42 | 40 |
| Environment or Climate | 38 | 38 |
| Human Rights or Human Capital/workforce | 14 | 14 |
| Shareholder Rights and Defenses | 12 | 9 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Broadcom Inc. | April 20, 2026 | $768M | 10 | 0 |
| Microsoft Corporation | December 5, 2025 | $749M | 21 | 6 |
| Apple Inc. | February 24, 2026 | $402M | 12 | 1 |
| Meta Platforms, Inc. | May 27, 2026 | $332M | 22 | 9 |
| Eli Lilly and Company | May 4, 2026 | $314M | 10 | 2 |
| Philip Morris International Inc. | May 6, 2026 | $270M | 13 | 1 |
| Amgen Inc. | May 19, 2026 | $254M | 15 | 1 |
| Marsh & McLennan Companies, Inc. | May 21, 2026 | $240M | 15 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| December 5, 2025 | Microsoft Corporation | European Security Program Censorship Risk Audit Shareholder proposal | Against | For |
| December 5, 2025 | Microsoft Corporation | Report on Risks of Censorship in Generative Artificial Intelligence Shareholder proposal | Against | For |
| February 24, 2026 | Apple Inc. | A shareholder proposal entitled "China Entanglement Audit" Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding report on Al data usage oversight. Shareholder proposal | Against | For |
| May 27, 2026 | Meta Platforms, Inc. | A shareholder proposal regarding annual vote regarding executive pay. Shareholder proposal | For | Against |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to adopt a policy and amend the bylaws to require an independent board chair. Shareholder proposal | For | Against |
| May 4, 2026 | Eli Lilly and Company | Shareholder proposal to prepare an annual lobbying report. Shareholder proposal | Against | For |
| May 6, 2026 | Philip Morris International Inc. | Shareholder Proposal to issue a report on filter cleanup costs and extended producer responsibility laws for filters Shareholder proposal | Against | For |
| May 19, 2026 | Amgen Inc. | Stockholder proposal to require an independent board chairman. Shareholder proposal | Against | For |
| June 1, 2026 | UnitedHealth Group Incorporated | If properly presented at the 2026 Annual Meeting of Shareholders, the shareholder proposal requesting the adoption of a policy to require any Board Chair to be independent. Shareholder proposal | Against | For |
| January 27, 2026 | Visa Inc. | Shareholder proposal requesting the Board of Directors to adopt a policy for an independent chair. Shareholder proposal | Against | For |
| January 27, 2026 | Visa Inc. | Shareholder proposal on shareholder right to act by written consent. Shareholder proposal | For | Against |
These funds reported the same votes as Tax-Exempt Fund of California in the latest season, so they share this page:
2,636 ballot items at 184 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, Tax-Exempt Fund of California (EXCAX) voted at 184 shareholder meetings of 180 companies, on 2,636 ballot items in all. Where management made a recommendation, the fund followed it on 93.1% of the items and voted against it 181 times. Its most frequent area of disagreement was corporate governance (71 of its votes against management). It voted FOR 23.6% of the 182 shareholder proposals on which it cast a FOR or AGAINST vote. It voted FOR the board's own proposals more often than Capital Group's funds as a whole (98.9% against 96.6%). It voted differently from most Capital Group funds on 4 items.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Capital Group’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.